The effects of glycosylation inhibitors on the proliferation of a Wilms tumour cell line

Anticancer Research

Volumn 20, Issue 2 A, 2000, Pages 689-692

  Granerus, Marika ^a   Engström, Wilhelm ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Cell proliferation; Tunicamycin; Wilms tumour

Indexed keywords

ANTINEOPLASTIC AGENT; CASTANOSPERMINE; GLUCOSAMINE; GLYCOSYLATION INHIBITING FACTOR; MEVALONIC ACID; SWAINSONINE; TUNICAMYCIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE S PHASE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GLYCOSYLATION; HUMAN; HUMAN CELL; NEPHROBLASTOMA; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION;

ANTINEOPLASTIC AGENTS; CELL DEATH; CELL DIVISION; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; GLYCOSYLATION; HUMANS; INDOLIZINES; KIDNEY NEOPLASMS; KINETICS; MEVALONIC ACID; NECROSIS; SWAINSONINE; TUNICAMYCIN; WILMS TUMOR;

EID: 0034056098     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Zetterberg A and Larsson O: Cell cycle progression and cell growth in mammalian cells. Kinetics of transition events. In: Cell cycle control (Hutchinson C and Glover DM, eds). Oxford, OUP, 1995, pp 206-227,
2. Engström W and Zetterberg A: Phosphate and the regulation of DNA replication in normal and virus transformed 3T3 cells. Biochem J 214: 695-702, 1983.
3. Roberts JD, Klein JL, Palmantier R, Dhume ST, George MD and Olden K: The role of protein glycosylation inhibitors in the prevention of metastasis and therapy of cancer. Cancer Detect Prev 22: 455-462, 1998.
4. Larsson O and Engström W: The role of N-linked glycosylation in the regulation of activity of 3-Hydroxy 3-Methyl Glutaryl CoA Reductase and proliferation in SV40 transformed cells. Biochem J 260: 597-600, 1989.
5. Engström W and Larsson O: The effects of glycosylation inhibitors on the proliferation of a spontaneously transformed cell line (3T6) in vitro. J Cell Science 90: 447-455, 1988.
6. Talts J, Aufderheide E, Sorokin L, Ocklind G, Mattsson R and Ekhlom P: Induction of mouse tenascin expression by a human sarcomatoid Wilms tumour cell line growing in nude mice. Int J Cancer 54: 868-874, 1993.
7. Hyldahl L, Engström W and Schofield PN: Stimulatory effects of insulin like growth factors on the human embryonic cornea. J Embryol Exptl Morphol 98: 71-83, 1986.
8. Larsson O, Dafgård E, Engström W and Zetterberg A: Immediate effects of serum depletion on dissociation between growth in size and cell division in proliferating 3T3 cells. J Cell Physiol 127: 267-273, 1986.
9. DeSantis R, Santer UV and Glick MC: NIH 3T3 cells transfected with human tumour DNA lose the transformed phenotype when treated with swainsonine. Biochem Biophys Res Comm 142: 348-353, 1987.
10. Goss PE, Baker MA, Carver JP and Dennis JW: Inhibitors of carbohydrate processing. A new class of anticancer agents. Clin Cancer Res 1: 935-944, 1995.
11. Elbein AD: Inhibitors of the biosynthesis and processing of N-linked oligosaccharides. CRC Crit Rev Biochem 16: 21-49, 1984,
12. Nishiura T, Karusono T, Yoshida H, Nakao H, Ogawa M, Horikawa Y, Yoshimura M, Okajima Y, Kanakura Y, Kanayama Y and Matsuzawa Y: Functional role of cation independent mannose 6 phosphate / insulin like growth factor II receptor in cell adhesion and proliferation of a human myeloma cell line OPM-2. Blood 88: 3546-3554, 1996.
13. Fuhrmann U, Bause E and Ploegh H: Inhibitors of oligosaccharide processing. Biochim Biophys Acta 825: 95-110, 1985.
14. Hadwiger A, Niemann H, Kabisch A, Bauer H and Tamura T: Appropriate glycosylation of the fms gene product is a prerequisite for its transforming potency. EMBO J 5: 689-694, 1989.
15. Carlberg M, Dricu A, Blegen H, Kass G, Orrenius S, Larsson O: Short exposures to tunicamycin induce apoptosis in SV40 transformed,but not in normal fibroblasts. Carcinogenesis 17: 2589-2596, 1996.